Piperacillin and Tazobactam
- Product NDC
- 65219-259
- 11-digit product format
- 652190259
- Labeler code
- 65219
- Product ID
- 65219-259_35f3281c-1865-4958-ae33-acdfbf8b1b28
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Piperacillin and Tazobactam
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA203719
- Marketing category
- ANDA
- Marketing start
- 2021-05-24
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 4; .5 g/20mL; g/20mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Piperacillin and Tazobactam
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PIPERACILLIN SODIUM | 4 g/20mL |
| TAZOBACTAM SODIUM | .5 g/20mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | M98T69Q7HP, UXA545ABTT |
| Rxcui | 1659149 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 65219-259-05 | Piperacillin and Tazobactam | 20 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 20 | | 4 |
| 65219-259-45 | Piperacillin and Tazobactam | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | | 4 |
| 65219-259-15 | Piperacillin and Tazobactam | 20 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 20 | | 1 |
| 65219-259-55 | Piperacillin and Tazobactam | 10 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 10 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 65219-259 | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20250516_a798faf5-cd97-4e35-a700-94c372978c46.zip |
| 65219-259 | PIPERACILLIN AND TAZOBACTAM INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC
] | 1 | Current NDC, Legacy NDC, 2 package rows | 20210524_b9bd733c-1176-42cb-b318-1223b7e48dcb.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 65219-259-05 | 65219025905 | 20 mL in 1 VIAL, SINGLE-USE | 20 ml | | | | | Historical |
| 65219-259-15 | 65219025915 | 20 mL in 1 VIAL, SINGLE-USE | 20 ml | | | | | Historical |
| 65219-259-45 | 65219025945 | 10 VIAL, SINGLE-USE in 1 CARTON (65219-259-45) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-05) | | 2018-05-18 | 0000-00-00 | No | No | Current |
| 65219-259-55 | 65219025955 | 10 VIAL, SINGLE-USE in 1 CARTON (65219-259-55) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-15) | | 2021-05-24 | 0000-00-00 | No | No | Current |